Voronoi Inc.

Voronoi Inc. is a leading biotechnology research company based in Incheon, South Korea, specializing in the development of innovative small molecule inhibitors of kinases and protein degraders. With a strong focus on advancing medical science, Voronoi Inc. is dedicated to creating solutions that address critical healthcare challenges. The company's primary address is 32, Songodogwahak-ro, Yeonsu-gu, IT-center bldg, 18F, Incheon, Incheon, KR.

Voronoi Inc. has established itself as a key player in the biotech industry, licensing out EGFR-Exon20Ins to ORIC Pharmaceuticals in 2020 and RET-Fusion to Inno.N in 2021. These strategic partnerships underscore Voronoi Inc.'s commitment to collaboration and its ability to bring groundbreaking research to market. The company continues to expand its portfolio and explore new opportunities for growth and innovation.

Voronoi Inc. is focused on making significant contributions to the biotechnology sector. We invite the manager of Voronoi Inc. to create a customized and exclusive company showcase and product listing on our platform, allowing you to further highlight the company's achievements and attract new partnerships.